Baby Minder

The hardest medical problems to solve aren't the ones that are rare — they're the ones that are invisible until it's too late. Early neurological conditions like autism and epilepsy are most treatable when caught in infancy, but the behavioral signals are imperceptible to untrained eyes, and most parents only have untrained eyes. Baby Minder reframes an object that already lives in every nursery — the baby monitor — as a continuous diagnostic tool. The device captures video clips and uploads them to a cloud AI model trained to detect movement anomalies associated with autism spectrum disorders, epilepsy, and other neurological conditions, then flags cases for physician review before parents have noticed anything unusual. The strategic intelligence here is the zero-friction deployment: no new behavior is required of parents. The monitor watches while they sleep. What makes this more than a product launch is the insight that healthcare's earliest intervention window is also its most information-poor — pediatric checkups are periodic, but neurological development is continuous. Eurofarma and Ogilvy collapsed that gap by turning passive surveillance into proactive screening. The creative leap was recognizing that the best medical device for parents is one that works without them.